# Trial of Preemptive Pharmacogenetics in Underserved Patients

> **NCT05141019** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 492 (estimated)

## Conditions studied

- Use of Prescription Medications
- Pharmacogenetic Testing

## Interventions

- **DIAGNOSTIC_TEST:** Panel-based pharmacogenetic genotyping

## Key facts

- **NCT ID:** NCT05141019
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2025-09-08
- **Final completion:** 2026-06-30
- **Target enrollment:** 492 (ESTIMATED)
- **Last updated:** 2025-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141019, "Trial of Preemptive Pharmacogenetics in Underserved Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05141019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*